SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-011398
Filing Date
2022-02-03
Accepted
2022-02-03 16:44:00
Documents
14
Period of Report
2022-02-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm225066d1_8k.htm   iXBRL 8-K 39657
2 EXHIBIT 10.1 tm225066d1_ex10-1.htm EX-10.1 84619
3 EXHIBIT 10.2 tm225066d1_ex10-2.htm EX-10.2 84151
  Complete submission text file 0001104659-22-011398.txt   428560

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vygr-20220201.xsd EX-101.SCH 3066
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vygr-20220201_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vygr-20220201_pre.xml EX-101.PRE 22617
8 EXTRACTED XBRL INSTANCE DOCUMENT tm225066d1_8k_htm.xml XML 3485
Mailing Address 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37625 | Film No.: 22589270
SIC: 2836 Biological Products, (No Diagnostic Substances)